Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
47
CC Quote, Financials, Valuation and Earnings
Last price:
$17.03
Seasonality move
:
13.12%
Day range:
$16.15 - $20.22
52-week range:
$9.13 - $21.85
Dividend yield:
3.01%
P/E ratio:
66.47x
P/S ratio:
0.44x
P/B ratio:
10.22x
Volume:
11.4M
Avg. volume:
3.7M
1-year change:
-2.52%
Market cap:
$2.6B
Revenue:
$5.8B
EPS (TTM):
-$2.48
Analysts' Opinion
-
Consensus RatingThe Chemours Co. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $16.67, The Chemours Co. has an estimated downside of -2.19% from its current price of $17.04.
-
Price Target UpsideAccording to analysts, the highest upside price target is $21.00 representing 23.24% upside increase from its current price of $17.04.
Fair Value
-
According to the consensus of 7 analysts, The Chemours Co. has -2.19% downside to fair value with a price target of $16.67 per share.
CC vs. S&P 500
-
Over the past 5 trading days, The Chemours Co. has underperformed the S&P 500 by -17.44% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
The Chemours Co. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
The Chemours Co. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter The Chemours Co. reported revenues of $1.3B.
Earnings Growth
-
The Chemours Co. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter The Chemours Co. reported earnings per share of -$0.31.
Enterprise value:
6.2B
EV / Invested capital:
1.36x
Price / LTM sales:
0.44x
EV / EBIT:
20.72x
EV / Revenue:
1.08x
PEG ratio (5yr expected):
--
EV / Free cash flow:
121.87x
Price / Operating cash flow:
50.23x
Enterprise value / EBITDA:
8.70x
Gross Profit (TTM):
$749M
Return On Assets:
-4.97%
Net Income Margin (TTM):
-6.42%
Return On Equity:
-93.92%
Return On Invested Capital:
-7.77%
Operating Margin:
6.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $6.1B | $5.8B | $5.8B | $1.4B | $1.3B | |
| Gross Profit | $1.3B | $1.2B | $749M | $272M | -- | |
| Operating Income | -$99M | $449M | -- | $77M | -- | |
| EBITDA | $208M | $750M | -- | $155M | -- | |
| Diluted EPS | -$1.60 | $0.49 | -$2.48 | -$0.05 | -$0.31 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.3B | $3.2B | $3.8B | $3B | $3B | |
| Total Assets | $7.6B | $7.6B | $8.3B | $7.5B | $7.4B | |
| Current Liabilities | $1.9B | $1.9B | $2.5B | $1.8B | $1.7B | |
| Total Liabilities | $6.5B | $6.5B | $7.5B | $6.9B | $7.1B | |
| Total Equity | $1.1B | $1.1B | $739M | $605M | $251M | |
| Total Debt | $3.9B | $3.8B | $4.2B | $4.3B | $4.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $556M | -$633M | $264M | $138M | $137M | |
| Cash From Investing | -$229M | -$353M | -$206M | -$107M | -$43M | |
| Cash From Financing | $172M | -$36M | -$126M | $85M | -$37M | |
| Free Cash Flow | $186M | -$993M | $51M | $29M | $92M | |
CC
Sector
Market Cap
$2.6B
$26.4M
Price % of 52-Week High
77.99%
72.39%
Dividend Yield
3.01%
0%
Shareholder Yield
3.87%
-3.28%
1-Year Price Total Return
-2.52%
21.34%
Beta (5-Year)
1.629
0.598
Dividend yield:
3.01%
Annualized payout:
$0.51
Payout ratio:
21.99%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$20.06
200-day SMA
Buy
Level
$13.64
Bollinger Bands (100)
Buy
Level
11.69 - 16.63
Chaikin Money Flow
Buy
Level
9.7M
20-day SMA
Sell
Level
$17.86
Relative Strength Index (RSI14)
Sell
Level
47.63
ADX Line
Sell
Level
46.91
Williams %R
Neutral
Level
-67.7465
50-day SMA
Buy
Level
$15.07
MACD (12, 26)
Buy
Level
4.56
25-day Aroon Oscillator
Buy
Level
36
On Balance Volume
Neutral
Level
14.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.3784)
Sell
CA Score
(Annual)
Level (-2.1945)
Sell
Beneish M-Score
(Annual)
Level (-1.6074)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (1.9069)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Other. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Other segment consists of performance chemicals and intermediates business. The company was founded on February 18, 2014 and is headquartered in Wilmington, DE.
Stock Forecast FAQ
In the current month, CC has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The CC average analyst price target in the past 3 months is $16.67.
-
Where Will The Chemours Co. Stock Be In 1 Year?
According to analysts, the consensus estimate is that The Chemours Co. share price will drop to $16.67 per share over the next 12 months.
-
What Do Analysts Say About The Chemours Co.?
Analysts are divided on their view about The Chemours Co. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that The Chemours Co. is a Sell and believe this share price will rise from its current level to $13.00.
-
What Is The Chemours Co.'s Price Target?
The price target for The Chemours Co. over the next 1-year time period is forecast to be $16.67 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is CC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for The Chemours Co. is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CC?
You can purchase shares of The Chemours Co. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase The Chemours Co. shares.
-
What Is The The Chemours Co. Share Price Today?
The Chemours Co. was last trading at $17.03 per share. This represents the most recent stock quote for The Chemours Co.. Yesterday, The Chemours Co. closed at $17.04 per share.
-
How To Buy The Chemours Co. Stock Online?
In order to purchase The Chemours Co. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get CC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CC
Sector
P/E ratio
66.47x
19.80x
PEG ratio
--
-0.02x
P/B ratio
10.22x
1.95x
Price / LTM sales
0.44x
1.75x
Growth Metrics
CC
Sector
Revenue growth
-6.74%
2.95%
Earnings growth
-485.02%
--
Revenue (5-year growth)
3.17%
3.5%
Earnings forecast
$0.02
$0.03
Profitability
CC
Sector
Profitability FY 2025
$902M
--
Return on invested capital
-7.77%
-10.03%
Return on assets
-4.97%
-11.46%
Return on equity
-93.92%
-10.39%
Earnings Date
Last Earnings Date
Feb
19
Next Earnings Date
May
5
Estimated Next Earnings Date
May
21
Balance Sheet
CC
Sector
Total cash
$672M
$2.6M
Short term investments
--
$223.7K
Total assets
$7.4B
$16.5M
Long term debt
$4.3B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
